Overrepresentation of glutamate signaling in alzheimer's disease: Network-based pathway enrichment using meta-analysis of genome-wide association studies

Vista sencilla de ítem
dc.contributor.authorPérez-Palma, Eduardo
dc.contributor.authorBustos, Bernabé I.
dc.contributor.authorVillamán, Camilo F.
dc.contributor.authorAlarcón, Marcelo A.
dc.contributor.authorAvila, Miguel E.
dc.contributor.authorUgarte, Giorgia D.
dc.contributor.authorReyes, Ariel E.
dc.contributor.authorOpazo, Carlos
dc.contributor.authorDe Ferrari, Giancarlo V.
dc.date.accessioned2023-06-13T16:06:41Z
dc.date.available2023-06-13T16:06:41Z
dc.date.issued2014-04
dc.descriptionIndexación: Scopuses
dc.description.abstractGenome-wide association studies (GWAS) have successfully identified several risk loci for Alzheimer’s disease (AD). Nonetheless, these loci do not explain the entire susceptibility of the disease, suggesting that other genetic contributions remain to be identified. Here, we performed a meta-analysis combining data of 4,569 individuals (2,540 cases and 2,029 healthy controls) derived from three publicly available GWAS in AD and replicated a broad genomic region (.248,000 bp) associated with the disease near the APOE/TOMM40 locus in chromosome 19. To detect minor effect size contributions that could help to explain the remaining genetic risk, we conducted network-based pathway analyses either by extracting gene wise p-values (GW), defined as the single strongest association signal within a gene, or calculated a more stringent gene based association p-value using the extended Simes (GATES) procedure. Comparison of these strategies revealed that ontological sub-networks (SNs) involved in glutamate signaling were significantly overrepresented in AD (p,2.7610211, p, 1.9610211; GW and GATES, respectively). Notably, glutamate signaling SNs were also found to be significantly overrepresented (p,5.161028 ) in the Alzheimer’s disease Neuroimaging Initiative (ADNI) study, which was used as a targeted replication sample. Interestingly, components of the glutamate signaling SNs are coordinately expressed in disease-related tissues, which are tightly related to known pathological hallmarks of AD. Our findings suggest that genetic variation within glutamate signaling contributes to the remaining genetic risk of AD and support the notion that functional biological networks should be targeted in future therapies aimed to prevent or treat this devastating neurological disorder.es
dc.description.urihttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0095413
dc.identifier.citationPLoS ONE. Volume 9, Issue 4. 22 April 2014. Article number e95413es
dc.identifier.doiDOI: 10.1371/journal.pone.0095413
dc.identifier.issn1932-6203
dc.identifier.urihttps://repositorio.unab.cl/xmlui/handle/ria/50611
dc.language.isoenes
dc.publisherPublic Library of Sciencees
dc.rights.licenseAtribution 4.0 International (CC BY 4.0)
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/deed.es
dc.subjectGlutamatees
dc.subjectAlzheimer's Diseasees
dc.subjectMetaanalysises
dc.subjectGene Ontologieses
dc.subjectGenome-Wide Association Studieses
dc.subjectSingle Nucleotide Polymorphismses
dc.subjectSynapseses
dc.subjectGenetics of Diseasees
dc.titleOverrepresentation of glutamate signaling in alzheimer's disease: Network-based pathway enrichment using meta-analysis of genome-wide association studieses
dc.typeArtículoes
Archivos
Bloque original
Mostrando 1 - 1 de 1
Miniatura
Nombre:
Perez-Palma_Overrepresentation_of_glutamate_signaling_in_Alzheimer's_disease.pdf
Tamaño:
1.56 MB
Formato:
Adobe Portable Document Format
Descripción:
TEXTO COMPLETO EN INGLÉS
Descargar
Bloque de licencias
Mostrando 1 - 1 de 1
No hay miniatura disponible
Nombre:
license.txt
Tamaño:
1.71 KB
Formato:
Item-specific license agreed upon to submission
Descripción:
Descargar
Colecciones
Fac.CV - Artículos de Revista